An investigator-initiated, open-label, single-center, proof-of-concept-study of omalizumab in patients with poorly controlled acute urticaria
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2017-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|